Cargando…

Fifteen-year trends in indications for enucleation from a tertiary care center in South India

AIM: To analyze the trends in clinicopathologic indications for enucleations over a 15-year period. MATERIALS AND METHODS: Clinicopathologic details of all eyes that underwent enucleation from January 1996 to December 2010 were drawn up from a computerized database. The study was divided into three...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Sabyasachi, Krishnakumar, Subramanian, Biswas, Jyotirmay, Gopal, Lingam, Khetan, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361811/
https://www.ncbi.nlm.nih.gov/pubmed/22569377
http://dx.doi.org/10.4103/0301-4738.95867
Descripción
Sumario:AIM: To analyze the trends in clinicopathologic indications for enucleations over a 15-year period. MATERIALS AND METHODS: Clinicopathologic details of all eyes that underwent enucleation from January 1996 to December 2010 were drawn up from a computerized database. The study was divided into three periods of 5 years each and comparison tables for each cause of enucleation during these periods were generated. Chi-square test was used to compare proportions. RESULTS: Out of a total 1467 enucleations performed during the study period, 693 (46%) were attributable to retinoblastoma, 189 (12.5%) to uveal melanoma, 228 (15%) to trauma, and 149 (10%) to phthisis bulbi. Intraocular tumors accounted for more than 63% of all enucleations performed. Over the three time periods, proportion of enucleations secondary to retinoblastoma increased from 38% in the 1(st) period to 58% in the 3(rd) period (P < 0.001). Enucleations for trauma showed statistically significant reduction in trends over the three periods (24% in the 1(st) period vs. 4.4% in the 3(rd) period, P < 0.001). Similar trends were also seen in the proportion of enucleations due to intractable glaucoma and chronic uveitis. The absolute number of enucleations secondary to retinoblastoma out of the total cases seen during the study period did not change over the three periods (range 51–60%). CONCLUSION: Intraocular tumors were the commonest indications for enucleation in our patient population despite the availability of globe-conserving treatments such as chemotherapy and radioactive plaques. We observed increasing trends in the proportion of enucleations due to retinoblastoma and reduction of enucleations secondary to trauma, chronic uveitis, and glaucoma.